In Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 No Comments Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Gold Price, Equities Flat as Fed Leaves Rates Unchanged June 19, 2025 RUA GOLD Announces Filing of Prospectus Supplement June 19, 2025 10 Silver ETFs for Every Investing Style in 2025 June 19, 2025